Trending News Today: Eli Lilly to Expand Cancer Drug Portfolio with Loxo Oncology Acquisition

On Monday, Eli Lilly announced it will acquire Loxo Oncology for $8 billion in cash to expand the company’s oncology treatment portfolio, Bloomberg reported. According to the article, Loxo is working on developing cancer treatments based on the genetic traits of tumors, regardless of where they are in the body. Loxo currently has 1 drug on the market, larotrectinib (Vitrakvi), for patients with a TRK fusion genetic mutation, according to the article.
A new study suggests that the risk of heart disease and premature death may be higher for those who experience sudden drops in income early in adulthood, Reuters reported. According to the article, the study showed that young adults with 2 or more significant drops in income over a 15-year period had more than twice the risk of developing heart disease and nearly twice the risk of dying early, compared with those who have a more stable income. For the study, the participants’ health status was checked every 6 months and they were asked about their income 5 times between 1990 and 2005, the article reported.
The Department of Justice (DOJ) is asking for an extension on an Obamacare lawsuit due to the government shutdown, The Hill reported. According to the article, Assistant Attorney General Jody Hunt said that DOJ lawyers are “unable to prepare their opposition at this time due to the lapse in appropriations.” Last week, Democrats filed a motion asking the court to allow the House to intervene as a defendant in the ongoing lawsuit against Obamacare, the article reported.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

Top news of the day from across the health care landscape.
A recent study demonstrates the clinical benefit from the use of direct-acting antivirals for hepatitis C virus in patients with a history of liver cancer.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.